Require Prescription
Description: Actemra (tocilizumab) is a biologic medication used to treat moderate to severe rheumatoid arthritis, giant cell arteritis, and cytokine release syndrome (CRS) associated with CAR T-cell therapy. It belongs to a class of drugs known as interleukin-6 (IL-6) receptor inhibitors, which help reduce inflammation.
Ingredients:
- Active Ingredient: Tocilizumab 162mg/0.9ml
- Other Ingredients: L-Histidine, L-Histidine Hydrochloride Monohydrate, Polysorbate 80, Sucrose, Water for Injection
Usage Instructions:
- Actemra is administered as an intravenous infusion by a healthcare professional.
- Dosage and frequency are determined based on the condition being treated and individual patient response.
- Follow the instructions provided by your doctor or healthcare provider.
Benefits:
- Effective in reducing signs and symptoms of rheumatoid arthritis and giant cell arteritis.
- Helps improve physical function and quality of life for patients with these conditions.
- Can mitigate severe CRS, a potentially life-threatening immune reaction.
Precautions:
- May increase the risk of infections. Avoid close contact with individuals who have contagious illnesses.
- Monitor for signs of infections during treatment and report any symptoms promptly to your healthcare provider.
- Discuss any history of infections, liver disease, or gastrointestinal perforations with your doctor before starting Actemra.
Storage Instructions:
- Store Actemra injections in the refrigerator (2-8°C).
- Protect from light.
- Do not freeze.
- Keep out of reach of children.
Manufacturer:
Roche Pharmaceuticals
